August 22, 2024 C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research and Drug Development C-Path is thrilled to announce its CPLD Consortium has been awarded a grant from the Ara Parseghian...
August 20, 2024 C-Path’s RDCA-DAP Announces Strategic Partnership with Vivli to Enhance Clinical Trials Data Sharing for Rare Diseases C-Path today announced a strategic data sharing partnership with Vivli, the nonprofit...
August 20, 2024 C-Path Receives Data Transfer from The Champ Foundation Registry C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...
August 15, 2024 Clinical Outcome Assessments — Second Public Discussion Enjoy the recording and slides from this August 15 CP-RND webinar.
August 14, 2024 C-Path to Host Tucson after5 Techmixer at Headquarters C-Path and the Arizona Technology Council invite you on August 14, from 5:30-7:30...
August 13, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project on Antibiotic-Resistant Gram-Negative Bacteria C-Path) Translational Therapeutics Accelerator (TRxA) announced today that Kenneth Keiler...
August 12, 2024 CPP CODR Database — Data Standards: Why are they needed? C-Path's Critical Path for Parkinson's (CPP) Consortium consultant Anne Pedata led this webinar on...
August 12, 2024 C-Path Welcomes CuraSen As Newest CPP Member C-Path is thrilled to welcome CuraSen Therapeutics as the newest member of its Critical Path for Parkinson’s Consortium.
August 8, 2024 C-Path’s TRxA Announces $250,000 Award for Drug Development Project in ALS C-Path)'sTranslational Therapeutics Accelerator (TRxA) announced today a new research grant awarded...
August 6, 2024 C-Path Welcomes New Advisory Members to Alpha-1 Antitrypsin Deficiency Consortium C-Path's Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) consortium today announced the addition of several...
